nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Tamoxifen—pancreatic cancer	0.131	0.199	CbGbCtD
Vecuronium—ABCB1—Gemcitabine—pancreatic cancer	0.113	0.172	CbGbCtD
Vecuronium—ABCB1—Erlotinib—pancreatic cancer	0.111	0.169	CbGbCtD
Vecuronium—ABCB1—Irinotecan—pancreatic cancer	0.101	0.153	CbGbCtD
Vecuronium—ABCB1—Docetaxel—pancreatic cancer	0.0738	0.112	CbGbCtD
Vecuronium—ABCB1—Sunitinib—pancreatic cancer	0.0734	0.112	CbGbCtD
Vecuronium—ABCB1—Doxorubicin—pancreatic cancer	0.055	0.0835	CbGbCtD
Vecuronium—Redness—Tamoxifen—pancreatic cancer	0.0108	0.0315	CcSEcCtD
Vecuronium—Paralysis—Tamoxifen—pancreatic cancer	0.0104	0.0306	CcSEcCtD
Vecuronium—Myopathy—Erlotinib—pancreatic cancer	0.0102	0.03	CcSEcCtD
Vecuronium—Myopathy—Sunitinib—pancreatic cancer	0.00887	0.026	CcSEcCtD
Vecuronium—Rash erythematous—Sunitinib—pancreatic cancer	0.00812	0.0238	CcSEcCtD
Vecuronium—Respiratory failure—Sunitinib—pancreatic cancer	0.00633	0.0185	CcSEcCtD
Vecuronium—Redness—Docetaxel—pancreatic cancer	0.00524	0.0154	CcSEcCtD
Vecuronium—Respiratory failure—Gemcitabine—pancreatic cancer	0.00508	0.0149	CcSEcCtD
Vecuronium—Injection site reaction—Gemcitabine—pancreatic cancer	0.00496	0.0145	CcSEcCtD
Vecuronium—Rash erythematous—Docetaxel—pancreatic cancer	0.00462	0.0135	CcSEcCtD
Vecuronium—Face oedema—Sunitinib—pancreatic cancer	0.00436	0.0128	CcSEcCtD
Vecuronium—Muscular weakness—Sunitinib—pancreatic cancer	0.00398	0.0117	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.00384	0.0112	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00374	0.011	CcSEcCtD
Vecuronium—Respiratory failure—Docetaxel—pancreatic cancer	0.0036	0.0106	CcSEcCtD
Vecuronium—Connective tissue disorder—Erlotinib—pancreatic cancer	0.00354	0.0104	CcSEcCtD
Vecuronium—Redness—Epirubicin—pancreatic cancer	0.00354	0.0104	CcSEcCtD
Vecuronium—Injection site reaction—Docetaxel—pancreatic cancer	0.00352	0.0103	CcSEcCtD
Vecuronium—Face oedema—Gemcitabine—pancreatic cancer	0.0035	0.0102	CcSEcCtD
Vecuronium—Paralysis—Epirubicin—pancreatic cancer	0.00344	0.0101	CcSEcCtD
Vecuronium—Flushing—Tamoxifen—pancreatic cancer	0.00338	0.0099	CcSEcCtD
Vecuronium—Redness—Doxorubicin—pancreatic cancer	0.00327	0.00958	CcSEcCtD
Vecuronium—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00325	0.00952	CcSEcCtD
Vecuronium—Paralysis—Doxorubicin—pancreatic cancer	0.00318	0.00931	CcSEcCtD
Vecuronium—Erythema—Tamoxifen—pancreatic cancer	0.00317	0.00929	CcSEcCtD
Vecuronium—Muscular weakness—Fluorouracil—pancreatic cancer	0.00314	0.00919	CcSEcCtD
Vecuronium—Erythema—Erlotinib—pancreatic cancer	0.00314	0.00919	CcSEcCtD
Vecuronium—Rash erythematous—Epirubicin—pancreatic cancer	0.00312	0.00913	CcSEcCtD
Vecuronium—Bronchospasm—Gemcitabine—pancreatic cancer	0.00308	0.00901	CcSEcCtD
Vecuronium—Connective tissue disorder—Sunitinib—pancreatic cancer	0.00307	0.00898	CcSEcCtD
Vecuronium—Injection site pain—Epirubicin—pancreatic cancer	0.00292	0.00856	CcSEcCtD
Vecuronium—Angioedema—Tamoxifen—pancreatic cancer	0.0029	0.00849	CcSEcCtD
Vecuronium—Cardiac disorder—Sunitinib—pancreatic cancer	0.0029	0.00848	CcSEcCtD
Vecuronium—Flushing—Sunitinib—pancreatic cancer	0.0029	0.00848	CcSEcCtD
Vecuronium—Rash erythematous—Doxorubicin—pancreatic cancer	0.00289	0.00845	CcSEcCtD
Vecuronium—Angiopathy—Sunitinib—pancreatic cancer	0.00283	0.00829	CcSEcCtD
Vecuronium—Immune system disorder—Sunitinib—pancreatic cancer	0.00282	0.00826	CcSEcCtD
Vecuronium—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00281	0.00824	CcSEcCtD
Vecuronium—Erythema—Sunitinib—pancreatic cancer	0.00272	0.00796	CcSEcCtD
Vecuronium—Injection site pain—Doxorubicin—pancreatic cancer	0.00271	0.00792	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00265	0.00777	CcSEcCtD
Vecuronium—Connective tissue disorder—Irinotecan—pancreatic cancer	0.00253	0.0074	CcSEcCtD
Vecuronium—Shock—Erlotinib—pancreatic cancer	0.00252	0.00738	CcSEcCtD
Vecuronium—Nervous system disorder—Erlotinib—pancreatic cancer	0.00251	0.00736	CcSEcCtD
Vecuronium—Skin disorder—Erlotinib—pancreatic cancer	0.00249	0.00729	CcSEcCtD
Vecuronium—Angioedema—Sunitinib—pancreatic cancer	0.00248	0.00727	CcSEcCtD
Vecuronium—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.00246	0.00721	CcSEcCtD
Vecuronium—Flushing—Irinotecan—pancreatic cancer	0.00239	0.00699	CcSEcCtD
Vecuronium—Cardiac disorder—Irinotecan—pancreatic cancer	0.00239	0.00699	CcSEcCtD
Vecuronium—Injection site reaction—Epirubicin—pancreatic cancer	0.00237	0.00695	CcSEcCtD
Vecuronium—Angiopathy—Irinotecan—pancreatic cancer	0.00233	0.00683	CcSEcCtD
Vecuronium—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00232	0.00681	CcSEcCtD
Vecuronium—Immune system disorder—Irinotecan—pancreatic cancer	0.00232	0.0068	CcSEcCtD
Vecuronium—Mediastinal disorder—Irinotecan—pancreatic cancer	0.00232	0.00679	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.0023	0.00673	CcSEcCtD
Vecuronium—Angiopathy—Gemcitabine—pancreatic cancer	0.00227	0.00665	CcSEcCtD
Vecuronium—Immune system disorder—Gemcitabine—pancreatic cancer	0.00226	0.00662	CcSEcCtD
Vecuronium—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00226	0.00661	CcSEcCtD
Vecuronium—Injection site reaction—Doxorubicin—pancreatic cancer	0.0022	0.00643	CcSEcCtD
Vecuronium—Bronchospasm—Docetaxel—pancreatic cancer	0.00218	0.0064	CcSEcCtD
Vecuronium—Shock—Sunitinib—pancreatic cancer	0.00218	0.00639	CcSEcCtD
Vecuronium—Erythema—Gemcitabine—pancreatic cancer	0.00218	0.00638	CcSEcCtD
Vecuronium—Nervous system disorder—Sunitinib—pancreatic cancer	0.00218	0.00637	CcSEcCtD
Vecuronium—Skin disorder—Sunitinib—pancreatic cancer	0.00215	0.00631	CcSEcCtD
Vecuronium—Erythema—Fluorouracil—pancreatic cancer	0.00214	0.00628	CcSEcCtD
Vecuronium—Urticaria—Tamoxifen—pancreatic cancer	0.00206	0.00602	CcSEcCtD
Vecuronium—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00191	0.00559	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00184	0.0054	CcSEcCtD
Vecuronium—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00183	0.00535	CcSEcCtD
Vecuronium—Shock—Irinotecan—pancreatic cancer	0.0018	0.00526	CcSEcCtD
Vecuronium—Nervous system disorder—Irinotecan—pancreatic cancer	0.00179	0.00525	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00179	0.00524	CcSEcCtD
Vecuronium—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00178	0.00521	CcSEcCtD
Vecuronium—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00175	0.00512	CcSEcCtD
Vecuronium—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00175	0.00511	CcSEcCtD
Vecuronium—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00175	0.00511	CcSEcCtD
Vecuronium—Skin disorder—Gemcitabine—pancreatic cancer	0.00173	0.00506	CcSEcCtD
Vecuronium—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00172	0.00502	CcSEcCtD
Vecuronium—Tachycardia—Fluorouracil—pancreatic cancer	0.00171	0.005	CcSEcCtD
Vecuronium—Hypotension—Irinotecan—pancreatic cancer	0.00171	0.005	CcSEcCtD
Vecuronium—Face oedema—Epirubicin—pancreatic cancer	0.00167	0.0049	CcSEcCtD
Vecuronium—Hypotension—Gemcitabine—pancreatic cancer	0.00166	0.00487	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00166	0.00485	CcSEcCtD
Vecuronium—Cardiac disorder—Docetaxel—pancreatic cancer	0.00165	0.00483	CcSEcCtD
Vecuronium—Flushing—Docetaxel—pancreatic cancer	0.00165	0.00483	CcSEcCtD
Vecuronium—Hypotension—Fluorouracil—pancreatic cancer	0.00164	0.00479	CcSEcCtD
Vecuronium—Hypersensitivity—Sunitinib—pancreatic cancer	0.00163	0.00478	CcSEcCtD
Vecuronium—Rash—Tamoxifen—pancreatic cancer	0.00163	0.00478	CcSEcCtD
Vecuronium—Dermatitis—Tamoxifen—pancreatic cancer	0.00163	0.00478	CcSEcCtD
Vecuronium—Rash—Erlotinib—pancreatic cancer	0.00162	0.00473	CcSEcCtD
Vecuronium—Dermatitis—Erlotinib—pancreatic cancer	0.00161	0.00473	CcSEcCtD
Vecuronium—Angiopathy—Docetaxel—pancreatic cancer	0.00161	0.00472	CcSEcCtD
Vecuronium—Immune system disorder—Docetaxel—pancreatic cancer	0.00161	0.0047	CcSEcCtD
Vecuronium—Mediastinal disorder—Docetaxel—pancreatic cancer	0.0016	0.00469	CcSEcCtD
Vecuronium—Face oedema—Doxorubicin—pancreatic cancer	0.00155	0.00453	CcSEcCtD
Vecuronium—Erythema—Docetaxel—pancreatic cancer	0.00155	0.00453	CcSEcCtD
Vecuronium—Muscular weakness—Epirubicin—pancreatic cancer	0.00153	0.00448	CcSEcCtD
Vecuronium—Muscular weakness—Doxorubicin—pancreatic cancer	0.00141	0.00414	CcSEcCtD
Vecuronium—Rash—Sunitinib—pancreatic cancer	0.0014	0.00409	CcSEcCtD
Vecuronium—Dermatitis—Sunitinib—pancreatic cancer	0.0014	0.00409	CcSEcCtD
Vecuronium—Urticaria—Fluorouracil—pancreatic cancer	0.00139	0.00407	CcSEcCtD
Vecuronium—Hypersensitivity—Irinotecan—pancreatic cancer	0.00135	0.00394	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00131	0.00383	CcSEcCtD
Vecuronium—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00129	0.00377	CcSEcCtD
Vecuronium—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00126	0.0037	CcSEcCtD
Vecuronium—Shock—Docetaxel—pancreatic cancer	0.00124	0.00364	CcSEcCtD
Vecuronium—Nervous system disorder—Docetaxel—pancreatic cancer	0.00124	0.00363	CcSEcCtD
Vecuronium—Tachycardia—Docetaxel—pancreatic cancer	0.00123	0.00361	CcSEcCtD
Vecuronium—Skin disorder—Docetaxel—pancreatic cancer	0.00123	0.00359	CcSEcCtD
Vecuronium—Hypotension—Docetaxel—pancreatic cancer	0.00118	0.00345	CcSEcCtD
Vecuronium—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00118	0.00345	CcSEcCtD
Vecuronium—Rash—Irinotecan—pancreatic cancer	0.00115	0.00337	CcSEcCtD
Vecuronium—Dermatitis—Irinotecan—pancreatic cancer	0.00115	0.00337	CcSEcCtD
Vecuronium—Rash—Gemcitabine—pancreatic cancer	0.00112	0.00329	CcSEcCtD
Vecuronium—Dermatitis—Gemcitabine—pancreatic cancer	0.00112	0.00328	CcSEcCtD
Vecuronium—Cardiac disorder—Epirubicin—pancreatic cancer	0.00111	0.00326	CcSEcCtD
Vecuronium—Flushing—Epirubicin—pancreatic cancer	0.00111	0.00326	CcSEcCtD
Vecuronium—Rash—Fluorouracil—pancreatic cancer	0.0011	0.00323	CcSEcCtD
Vecuronium—Dermatitis—Fluorouracil—pancreatic cancer	0.0011	0.00323	CcSEcCtD
Vecuronium—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00109	0.00319	CcSEcCtD
Vecuronium—Angiopathy—Epirubicin—pancreatic cancer	0.00109	0.00318	CcSEcCtD
Vecuronium—Immune system disorder—Epirubicin—pancreatic cancer	0.00108	0.00317	CcSEcCtD
Vecuronium—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00108	0.00316	CcSEcCtD
Vecuronium—Erythema—Epirubicin—pancreatic cancer	0.00104	0.00306	CcSEcCtD
Vecuronium—Flushing—Doxorubicin—pancreatic cancer	0.00103	0.00301	CcSEcCtD
Vecuronium—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00103	0.00301	CcSEcCtD
Vecuronium—Angiopathy—Doxorubicin—pancreatic cancer	0.00101	0.00295	CcSEcCtD
Vecuronium—Immune system disorder—Doxorubicin—pancreatic cancer	0.001	0.00293	CcSEcCtD
Vecuronium—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.001	0.00293	CcSEcCtD
Vecuronium—Erythema—Doxorubicin—pancreatic cancer	0.000966	0.00283	CcSEcCtD
Vecuronium—Hypersensitivity—Docetaxel—pancreatic cancer	0.000931	0.00272	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000883	0.00258	CcSEcCtD
Vecuronium—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000852	0.00249	CcSEcCtD
Vecuronium—Shock—Epirubicin—pancreatic cancer	0.000838	0.00245	CcSEcCtD
Vecuronium—Nervous system disorder—Epirubicin—pancreatic cancer	0.000835	0.00245	CcSEcCtD
Vecuronium—Tachycardia—Epirubicin—pancreatic cancer	0.000831	0.00243	CcSEcCtD
Vecuronium—Skin disorder—Epirubicin—pancreatic cancer	0.000827	0.00242	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000817	0.00239	CcSEcCtD
Vecuronium—Rash—Docetaxel—pancreatic cancer	0.000796	0.00233	CcSEcCtD
Vecuronium—Hypotension—Epirubicin—pancreatic cancer	0.000796	0.00233	CcSEcCtD
Vecuronium—Dermatitis—Docetaxel—pancreatic cancer	0.000796	0.00233	CcSEcCtD
Vecuronium—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000788	0.00231	CcSEcCtD
Vecuronium—Shock—Doxorubicin—pancreatic cancer	0.000775	0.00227	CcSEcCtD
Vecuronium—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000773	0.00226	CcSEcCtD
Vecuronium—Tachycardia—Doxorubicin—pancreatic cancer	0.000769	0.00225	CcSEcCtD
Vecuronium—Skin disorder—Doxorubicin—pancreatic cancer	0.000766	0.00224	CcSEcCtD
Vecuronium—Hypotension—Doxorubicin—pancreatic cancer	0.000737	0.00216	CcSEcCtD
Vecuronium—Urticaria—Epirubicin—pancreatic cancer	0.000677	0.00198	CcSEcCtD
Vecuronium—Hypersensitivity—Epirubicin—pancreatic cancer	0.000628	0.00184	CcSEcCtD
Vecuronium—Urticaria—Doxorubicin—pancreatic cancer	0.000626	0.00183	CcSEcCtD
Vecuronium—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000581	0.0017	CcSEcCtD
Vecuronium—Rash—Epirubicin—pancreatic cancer	0.000537	0.00157	CcSEcCtD
Vecuronium—Dermatitis—Epirubicin—pancreatic cancer	0.000537	0.00157	CcSEcCtD
Vecuronium—Rash—Doxorubicin—pancreatic cancer	0.000497	0.00145	CcSEcCtD
Vecuronium—Dermatitis—Doxorubicin—pancreatic cancer	0.000497	0.00145	CcSEcCtD
